À propos de cet article

Citez

1. Sherif SO, Salama EE, Abdel-Wahhab MA. Mycotoxins and child health: the need for risk assessment. Int J Hyg Environ Health 2009;212:347-68. doi: 10.1016/j.ijheh.2008.08.00210.1016/j.ijheh.2008.08.002Search in Google Scholar

2. Domijan A-M, Peraica M. Carcinogenic mycotoxins. In: Comprehensive Toxicology, Vol.14, (Ed. McQueen A) Academic Press, Oxford 2010 pp. 125-137.10.1016/B978-0-08-046884-6.01408-1Search in Google Scholar

3. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Vol 82. Lyon: IARC; 2002.Search in Google Scholar

4. Wojnowski L, Turner P C, Pedersen B, Hustert E, Brockmoller J, Maimuna M, Hilton C, Greg K, Wild CP. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphism in the Gambia, West Africa. Pharmacogenetics 2004;14:691-700. doi: 10.1097/00008571-200410000-0000710.1097/00008571-200410000-00007Search in Google Scholar

5. Guengerich FP. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys 2003;409:59-71. PMID: 1246424510.1016/S0003-9861(02)00415-0Search in Google Scholar

6. Hengstler JG, van der Burg B, Steinberg P, Oesch F. Interspecies differences in cancer susceptibility and toxicity. Drug Metabol Rev 1999;31:917-70. PMID: 1057555510.1081/DMR-100101946Search in Google Scholar

7. Klein PJ, Buckner R, Kelly J, Coulombe RA Jr. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B1. Toxicol Appl Pharmacol 2000;165:45-52. doi: 10.1006/ taap.2000.892610.1006/taap.2000.8926Search in Google Scholar

8. Jackson PE, Groopman JD. Aflatoxin and liver cancer. Baillieres Best Pract Res Clin Gastroenterol 1999;13:545-55. PMID: 1065491910.1053/bega.1999.0047Search in Google Scholar

9. Turner PC, Sylla A, Kuang SY, Marchant CL, Diallo MS, Hall AJ, Groopman JD, Wild CP. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure. Cancer Epidemiol Biomarkers Prev 2005;14:2053-55. PMID: 1610346110.1158/1055-9965.EPI-04-0923Search in Google Scholar

10. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-years-old. Vaccine 2001;19:3919-26. PMID: 1142726610.1016/S0264-410X(01)00120-7Search in Google Scholar

11. Ediage EN, Di Mavungu JD, Song S, Sioen I, De Saeger S. Multimycotoxin analysis in urines to assess infant exposure: A case study in Cameroon. Envirn Int 2013;57-58; 50-9. doi: 10.1016/j.envint.2013.04.00210.1016/j.envint.2013.04.00223669720Search in Google Scholar

12. Amla I, Kamala CS, Gopalakrishna GS, Jayaraj AP, Sreenivasamurthy V, Parpia HAB. Cirrhosis in children from peanut meal contaminated by aflatoxin. Am J Clin Nutr 1971;24:609-14. PMID: 558100010.1093/ajcn/24.6.609Search in Google Scholar

13. Krisnamashari KAVR, Bhat RV, Nagarajan V, Tilak TBG. Hepatitis due to aflatoxicosis. Lancet 1975;1:1061-3. doi: 10.1016/S0140-6736(75)91829-210.1016/S0140-6736(75)91829-2Search in Google Scholar

14. Tandon BN, Krishnamurthy L, Koshy A, Tandon HD, Ramalingaswami V, Bhandari JR, Mathur MM, Mathur PD. Study of an epidemic of jaundice, presumably due to toxic hepatitis, in Northwest India. Gastroenterology 1977;72:488-94. PMID: 83279710.1016/S0016-5085(77)80262-XSearch in Google Scholar

15. Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, Nandwa H, Omondi TN, Jansen AJ, Ngare W, Kaviti JN, Gatei D, Siongok TA. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet 1982;319:1346-8. doi: 10.1016/S0140-6736(82)92411-410.1016/S0140-6736(82)92411-4Search in Google Scholar

16. Obura A. Aflatoxicosis: evidence from Kenya [displayed 22 July 2014]. Available at http://www.ifpri.org/sites/default/files/publications/focus20_02.pdfSearch in Google Scholar

17. Lamplugh SM, Hendrickse RG, Apeagyei F, Mwanmut DD. Aflatoxins in breast milk, neontal cord blood, and serum of pregnant women. Br Med J 1988;296:968. doi: 10.1136/ bmj.296.6627.96810.1136/bmj.296.6627.96825454373129110Search in Google Scholar

18. Abdulrazzaq YM, Osman N, Ibrahim A. Fetal exposure to aflatoxins in United Arab Emirates. Ann Trop Paediatr 2003;22:3-9. doi: 10.1179/02724930212500009410.1179/02724930212500009411926047Search in Google Scholar

19. Turner PC, Collinson AC, Cheung YB, Gong YY, Hall AJ, Prentice AM, Wild CP. Aflatoxin exposure in utero causes growth flatering in Gambian infants. Int J Epidemiol 2007;36:1119-25. doi: 10.1093/ije/dym12210.1093/ije/dym12217576701Search in Google Scholar

20. Mahdavi R, Nikniaz L, Arefhosseini SR, Vahed Jabbari M. Determination of aflatoxin M1 in breast milk samples in Tabriz-Iran. Matern Child Health J 2010;14;141-5. doi: 10.1007/s10995-008-0439-910.1007/s10995-008-0439-919093194Search in Google Scholar

21. Zarba A, Wild CP, Hall AJ, Montesano R, Hudson GJ, Groopman JD. Aflatoxin M1 in human breast milk from Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Caracinogenesis 1992;13:891-4. PMID: 158700410.1093/carcin/13.5.8911587004Search in Google Scholar

22. Adejumo O, Atanda O, Raiola A, Somorin Y, Bandyopadhyay R, Ritieni A. Correlation between aflatoxin M1 content of breast milk, dietary exposure to aflatoxin B1 and socieconomic status of lactating mothers in Ogun State, Nigeria. Food Chem Toxicol 2013;56:171-7. doi: 10.1016/j.fct.2013.02.02710.1016/j.fct.2013.02.02723462105Search in Google Scholar

23. Gong YY, Hounsa A, Egal S, Turner PC, Sutcliffe AE, Hall AJ, Cardwell K, Wild CP. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ Health Perspect 2004;112:1334-8. PMID: 1534534910.1289/ehp.6954124752615345349Search in Google Scholar

24. Tchana AN, Moundipa PF, Tchouanguep FM. Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon. Int J Environ Res Public Health 2010;7:178-88. doi: 10.3390/ ijerph701017810.3390/ijerph7010178281978320195440Search in Google Scholar

25. El-Sayed AA, Soher ES, Neamat-Allah AA. Human exposure to mycotoxins in Egypt. Mycotox Res 2002;18:23-30. doi: 10.1007/BF0294613610.1007/BF0294613623605947Search in Google Scholar

26. Polychronaki N, West RM, Turner PC, Amra H, Abdel- Wahhab M, Mykkänen H, El-Nezami H. A logitudinal assessment of aflatoxin M1 excretion in breast milk of selected Egyptian mothers. Food Chem Toxicol 2007;45:1210-5. doi: 10.1016/j.fct.2007.01.00110.1016/j.fct.2007.01.00117306915Search in Google Scholar

27. El-Tras WF, El-Kady NN, Tayel AA. Infants exposure to aflatoxin M1 as a novel foodborne zoonosis. Food Chem Toxicol 2011;49:2816-9. doi: 10.1016/j.fct.2011.08.00810.1016/j.fct.2011.08.00821864634Search in Google Scholar

28. Coulter JB, Lamplugh SM, Suliman GL, Omer MI, Hendrickse RG. Aflatoxins in human breast milk. Ann Trop Pediatr 1984;4:61-6. PMID: 608374710.1080/02724936.1984.117483116083747Search in Google Scholar

29. Elzupir AO, Abas AR, Fadul MH, Modwi Ak, Ali NM, Jadian AF, Ahmed NA, Adam SY, Ahmed NA, Kahiry AA, Khalil EA. Aflatoxin M1 in breast milk of nursing Sudanese mothers. Mycotoxin Res 2012;28:131-4. doi: 10.1007/ s12550-012-0127-x10.1007/s12550-012-0127-x23606051Search in Google Scholar

30. Wild CP, Pionneau FA, Montesanto R, Mutiro CF, Chetsanga CJ. Aflatoxin detected in human breast milk by immunoassay. Int J Cancer 1987;40:328-33. doi: 10.1002/ijc.291040030810.1002/ijc.29104003083623716Search in Google Scholar

31. Sharaf OS. Incidence of aflatoxin M1 in human milk and animal milk from Jordan. J Toxicol Environ Health 2012;75:1404-9. doi: 10.1080/15287394.2012.72117410.1080/15287394.2012.72117423095158Search in Google Scholar

32. Ghiasain SA, Maghsood AH. Infants’s exposure to aflatoxin M1 from mother’s breast milk in Iran. Iran J Publ Health 2012;41:119-26. PMCID: PMC3481700Search in Google Scholar

33. Afsahar P, Shokrzadeh M, Kalhori S, Babaee Z, Saeedi Saravi SS. Occurrence of ochratoxin A and aflatoxin M1 in human breast milk in Sari, Iran. Food Control 2013;31:525-9. doi: 10.1016/j.foodcont.2012.12.00910.1016/j.foodcont.2012.12.009Search in Google Scholar

34. Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Boyani H, Jannat F. Incidence of aflatoxin M1 in human breast milk in Tehran, Iran. Food Control 2009;20:75-8. doi: 10.1016/j. foodcont.2008.02.005Search in Google Scholar

35. Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccaraini L, Castellazzi AM, Pietri A, Piva G. Evaluation of xenobiotics in human milik and ingestion by newborn - an epidemiological survey in Lombardi (Northern Italy). Eur J Nutr 2004;43:191-7. PMID: 1530943710.1007/s00394-004-0458-215309437Search in Google Scholar

36. Galvano F, Pietri A, Bertuzzi T, Gagliardi L, Ciotti S, Luisi S, Bognano M, La Fauci L, Iacopino AM, Nigro F, Li Volti G, Vanella L, Giammanco G, Tina GL, Gazzolo D. Maternal dietary habits and mycotoxin occurrence in human mature milk. Mol Nutr Food Res 2008;52:496-501. doi: 10.1002/ mnfr.20070026610.1002/mnfr.20070026618338407Search in Google Scholar

37. Gürbay A, Sabuncuoglu SA, Girgin G, Sahin G, Yigit S, Yurdakok M, Tekinalp G. Exposure of newborns to aflatoxin M1 and B1 from mothers’ breast milk in Ankara, Turkey. Food Chem Toxicol 2010;48:314-9. doi: 10.1016/j. fct.2009.10.016Search in Google Scholar

38. Navas SA, Sabino M, Rodriguez-Amaya DB. Aflatoxin M1 and ochratoxin A in a human milk bank in the city of São Paolo, Brazil. Food Addit Contam 2005;22:457-62. PMID: 1601981810.1080/0265203050011055016019818Search in Google Scholar

39. Andrade PD, Gomes da Silva JL, Dutra Caldas ED. Simultaneous analysis of aflatoxins B1, B2, G1, G2, M1 and ochratoxin A in breast milk by high-performance liquid chromatography/fluorescence after liquid-liquid extraction with low temperature purification (LLE-LTP). J Chromatography A 2013;1304:61-8. doi: 10.1016/j. chroma.2013.06.049Search in Google Scholar

40. Iha MH, Barbosa CB, Heck AR, Trucksess MW. Aflatoxin M1 and ochratoxin A in human milk in Ribeirão Preto-SP, Brazil. Food Control 2014;40:310-3. doi: 10.1016/j. foodcont.2013.12.014Search in Google Scholar

41. Turner PC, Mendy M, Whittle H, Fortuin M, Hall AJ, Wild CP. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health 2000;5:837-41. PMID: 1116927110.1046/j.1365-3156.2000.00664.x11169271Search in Google Scholar

42. Gong YY, Egal S, Hounsa A, Turner PC, Hall AJ, Cardwell KF, Wild CP. Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Int J Epidemiol 2003;32:556-62. PMID: 1291302910.1093/ije/dyg10912913029Search in Google Scholar

43. El-Morsi DA, Shabaan S, Abdelhamid AM, Mehrim AI, Shoulman BO. Aflatoxin B1 level in relation to child’s feeding and growth. Mansoura J Forensic Med Clin Toxicol 2010;28:1-13.10.21608/mjfmct.2010.54240Search in Google Scholar

44. Tonon KM, Reiter MGR, Scussel VM. Mycotoxins levels in human milk: a menace to infants and children health. Curr N u t r F o o d S c i 2 0 1 3 ; 9 : 3 3 - 4 2 . d o i : 10.2174/1573401311309010007Search in Google Scholar

45. Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. Mycotoxins: Occurence, toxicology and exposure assessment. Food Chem Toxicol 2013;60:218-37. doi: 10.1016/j.fct.2013.07.04710.1016/j.fct.2013.07.04723907020Search in Google Scholar

46. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, Wild CP. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. Br Med J 2002;325:20-1. doi: 10.1136/bmj.325.7354.2010.1136/bmj.325.7354.2011666712098724Search in Google Scholar

47. Chen SY, Chen CJ, Chou SR, Hsieh LL, Wang LY, Tsai WY, Ahsan H, Santella RM. Association if aflatoxin B1-albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan. Cancer Epidemiol Biomarkers Prev 2001;10:1223-6. PMID: 11700273Search in Google Scholar

48. Polychronaki N, Wild CP, Mykkänen H, Amra H, Abdel- Wahhab M, Sylla A, Diallo M, El-Nezami H, Turner PC. Urinary biomarkers of aflatoxin exposure in young children from Egypt and Guinea. Food Chem Toxicol 2008;46:519-26. doi: 10.1016/j.fct.2007.08.03410.1016/j.fct.2007.08.03417920747Search in Google Scholar

49. Jonsyn-Ellis FE. Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopatologia 2000;152:35-40. doi: 10.1023/A:101195051267510.1023/A:1011950512675Search in Google Scholar

50. Jiang Y, Jolly PE, Ellis WO, Wang J-S, Phillips TD, Williams JH. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol 2005;17:807-14. doi: 10.1093/intimm/dxh26210.1093/intimm/dxh262Search in Google Scholar

51. Denning DW, Quiepo SC, Altman DG, Makarananda K, Neal GE, Camallere EL, Morgan MR, Tupasi TE. Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines. Ann Trop Pediatr 1995;15:209-16. PMID: 853403910.1080/02724936.1995.11747774Search in Google Scholar

52. Oyelami OA, Maxwell SM, Adelusola KA, Aladekoma TA, Olyelese AO. Aflatoxins in the lungs of children with kwashiorkor and children with miscellaneous diseases in Nigeria. J Toxicol Environ Health 1997;51:623-8. PMID: 924223210.1080/00984109708984048Search in Google Scholar

53. Jonsyn-Ellis FE. Ignored aetiologic factors of growth faltering/stunting in Sierra Leonean Children: aflatoxin and ochratoxin A. Sierra Leone J Biomed Res 2012;4:14-21.Search in Google Scholar

54. Sodeinde O, Chan MCK, Maxwell SM, Familusi JB, Hendrickse RG. Neonatal jaundice, aflatoxins and naphtols: report of a study in Ibadan, Nigeria. Ann Trop Pediatr 1995;15:107-13. PMID: 767741010.1080/02724936.1995.11747757Search in Google Scholar

55. Gong YY, Wilson S, Mwatha JK, Routledge MN, Castelino JM, Zhao B, Kimani G, Kuruki HC, Vannervald BJ, Dunne DW, Wild CP. Aflatoxin exposure may contribute to chronic hepatomegaly in Kenyan school children. Environ Health Perspect 2012;120:893-6. doi: 10.1289/ehp.110435710.1289/ehp.1104357Search in Google Scholar

56. McGovern MC, Glasgow JFT, Stewart MC, Reye’s syndrome and aspirin: lest we forget. Brit Med J 2001:322:1591-2.10.1136/bmj.322.7302.1591Search in Google Scholar

57. Schror K. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs 2007; 9:195-204.10.2165/00148581-200709030-00008Search in Google Scholar

58. International Programme on Chemical Safety (IPCS). Safety evaluation of certain mycotoxins in food. WHO Food Additives Series. Vol 47. Geneva: WHO; 2001.Search in Google Scholar

59. Zepnik H, Völkel W, Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 2003;192:36-44. PMID: 1455410110.1016/S0041-008X(03)00261-8Search in Google Scholar

60. Studer-Rohr I, Schlatter J, Dietrich DR. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 2000;74:499-510. PMID: 1113102910.1007/s00204000015711131029Search in Google Scholar

61. Ringot D, Chango A, Schneider Y-J, Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact 2006;159:18-46. PMID: 1629323510.1016/j.cbi.2005.10.10616293235Search in Google Scholar

62. Želježić D, Domijan A-M, Peraica M. DNA damage by ochratoxin A in rat kidney assessed by alkaline comet assay. Braz J Med Biol Res 2006;39:1563-8. PMID: 1716026410.1590/S0100-879X2006001200006Search in Google Scholar

63. Domijan A-M, Želježić D, Kopjar N, Peraica M. Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B1-treated rats. Toxicology 2006;222:53-9. doi: 10.1016/j.tox.2006.01.02410.1016/j.tox.2006.01.024Search in Google Scholar

64. Šegvić Klarić M, Želježić D, Rumora L, Peraica M, Pepeljnjak S, Domijan A-M. A potential role of carlcium in apoptosis and aberrant chromatin forms in porcine kidney PK15 cells induced by individual and combined ochratoxin a and citrinin. Arch Toxicol 2012;86:97-107.10.1007/s00204-011-0735-9Search in Google Scholar

65. Limonciel A, Jennings P. A review of evidence that ochratoxin A is a NrF2 inhibitor:Implications for nephrotoxicity and renal carcinogenicity. Toxins 2014;6:371-379. doi: 10.3390/ toxins601037110.3390/toxins6010371Search in Google Scholar

66. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Vol 56. Lyon: IARC; 1993.Search in Google Scholar

67. Di Paolo N, Guarnieri A, Garossi G, Sacchi G, Mangiarotti AM, Di Paolo M. Inhaled mycotoxins lead to acute renal failure. Nephrol Dial Transplant 1994;9(Suppl 4):116-20. PMID: 7800243Search in Google Scholar

68. Miletić-Medved M, Domijan A-M, Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia. Wien Klin Wochenschr 2005;117:604-9. PMID: 1639599010.1007/s00508-005-0426-8Search in Google Scholar

69. Pfohl-Leszkowicz A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 2009;60:465-83. doi: 10.2478/10004-1254-60-2009-200010.2478/10004-1254-60-2009-2000Search in Google Scholar

70. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: and overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007;51:61-99. PMID: 1719527510.1002/mnfr.200600137Search in Google Scholar

71. Peraica M, Domijan A-M, Fuchs R. Lucić A, Radić B. The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 1999:110:105-12. PMID: 1059360110.1016/S0378-4274(99)00141-1Search in Google Scholar

72. Peraica M, Domijan A-M, Matašin M, Lucić A, Radić B, Delaš F, Horvat I, Bosanac I, Balija M, Grgičević D. Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch Toxicol 2001;75:410-4. PMID: 1169318210.1007/s00204010025811693182Search in Google Scholar

73. Fuchs R, Peraica M. Ochratoxin A in human kidney diseases. Food Addit Contam 2005; 22 (Suppl 1).53-57. doi:10.1080 /02652030500030936895.10.1080/0265203050030936816332622Search in Google Scholar

74. Verger Ph, Counil E, Tressou J, Leblanc JC. Some recent advances in modelling dietary exposure to ochratoxin A. Food Add Contam 2005; 22(supl 1): 94-98. doi: 10.1080/0265203050041028110.1080/02652030500410281Search in Google Scholar

75. EFSA. Opinion of the Scientific Panel on contaminants in the food chain on a request from the Commission related to ochratoxin A in food. EFSA J 2006; 365: 1-56.Search in Google Scholar

76. Zimmerli B, Dick R. Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B Biomed Appl 1995;666:85-99. PMID: 765562510.1016/0378-4347(94)00569-QSearch in Google Scholar

77. Muñoz K, Campos V, Blaszkewicz M, Vega M, Alvarez A, Neira J, Degen GH. Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile. Mycotoxin Res 2010;26:59-67. doi: 10.1007/s12550-009-0040-010.1007/s12550-009-0040-023605309Search in Google Scholar

78. Hassan AH, Sheashaa HA, Fattah MFA, Ibrahim AZ, Gaber OA, Sobh MA. Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infants. Pediatr Nephrol 2006;21:102-5. doi: 10.1007/s00467-005-2033-310.1007/s00467-005-2033-316235098Search in Google Scholar

79. Jonsyn FE, Maxwell SM, Hendrickse RG. Ochratoxin A and aflatoxins in breast milk samples from Sierra Leone. Mycopathologia 1995;131:121-6. doi: 10.1007/BF0110289010.1007/BF011028908532055Search in Google Scholar

80. Muñoz K, Blaszkewicz M, Campos V, Vega M, Degen GH. Exposure of infants to ochratoxin with breast milk. Arch Toxicol 2014;88:837-846. doi: 10.1007/s00204-013-1168-410.1007/s00204-013-1168-424270973Search in Google Scholar

81. Apostolou E, E-Nezami HS, Ahokas JT, Donohue DC. The evaluation of ochratoxin A in breast milk in Victoria (Australia). Revue Méd Vét 1998;149:709.Search in Google Scholar

82. Micco C, Ambruzzi MA, Miraglia M, Brera C, Onori R, Benelli L. Contamination of human milk with ochratoxin A. In: Castegnaro M, Pleština R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications No.Search in Google Scholar

115. Lyon: IARC; 1991. p. 105-11 83. Micco C, Miraglia M, Brera C, Corneli S, Ambruzzi A. Evaluation of ochratoxin A level in human milk in Italy. Food Addit Contam 1995;12:351-4. PMID: 766492710.1080/026520395093743147664927Search in Google Scholar

84. Miraglia M, Brera C, Cava E, Calfapietra FR. The evaluation of major sources of ochratoxin A (OA) intake through the analysis of OA in biological fluids in Italy. Revue Méd Vét 1998;149:711.Search in Google Scholar

85. Skaug MA, Størmer FC, Saugstad OD. Ochratoxin A: a naturally occurring mycotoxin found in human milk samples from Norway. Acta Paediatr 1998;87:1275-8. doi: 10.1111/ j.1651-2227.1998.tb00951.x10.1111/j.1651-2227.1998.tb00951.xSearch in Google Scholar

86. Skaug MA, Helland I, Solvoll K, Saugstad OD. Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 2001;18:321-7. PMID: 1133926710.1080/0265203011774011339267Search in Google Scholar

87. Dostal A, Jakusova L, Cajdova J, Hudeckova H. Results of the first studies of occurrence of ochratoxin A in human milk in Slovakia. Bratisl Lek Listy 2008;109:276-8. PMID: 18700441Search in Google Scholar

88. Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K. Ochratoxin A in cow’s milk and in human milk with corresponding human blood samples. J AOAC Int 1993;76:842-6. PMID: 837432910.1093/jaoac/76.4.842Search in Google Scholar

89. Schwartz GG. Hypothesis: does ochratoxin A cause testicular cancer? Cancer Causes Contr 2002;13:91-100. PMID: 1189912210.1023/A:1013973715289Search in Google Scholar

90. Pestka JJ, Zhou HR, Moon Y, Chung YJ. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett 2004;153:61-73. PMID: 1534208210.1016/j.toxlet.2004.04.023Search in Google Scholar

91. Antonissen G, Martel A, Pasmans F, Ducatelle R, Verbrugghe E, Vandenbroucke V, Li S, Haesebrouck F, Van Immerseel F, Croubels S. The impact of fusarium mycotoxins on human and animal host susceptibility to infectious diseases. Toxins 2014; 6:430-52. doi: 10.3390/toxins602043010.3390/toxins6020430Search in Google Scholar

92. EFSA. Scientific opinion on risk for animal and public health related to the presence of nivalenol in food and feed. EFSA J 2013;11:1-119. doi: 10.2903/j.efsa.2013.326210.2903/j.efsa.2013.3262Search in Google Scholar

93. EFSA. Deoxynivalenol in food and feed: occurrence and exposure. EFSA J 2013:11:1-56. doi: 10.2903/j. efsa.2013.3379Search in Google Scholar

94. EFSA. Scientific opinion on the risks for animal and public health related to the presence of T-2 and HT-2 toxin in food and feed. EFSA J 2011;9:1-187. doi: 10.2903/j.efsa.2011.248110.2903/j.efsa.2011.2481Search in Google Scholar

95. Gajdušek DC. Acute Infectious Hemorrhagic Fevers Mycotoxicoses in the Union of Soviet Socialist Republics. Medical Science Publications No 2. Washington: Walter Reed Army Medical Center; 1953.Search in Google Scholar

96. Bhat RV, Beedu SR, Ramakrishna Y, Munsh KL. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir Valley, India. Lancet 1989;333:35-7. doi: 10.1016/S0140-6736(89)91684-X10.1016/S0140-6736(89)91684-XSearch in Google Scholar

97. Rubert J, Leon N, Saez C, Martins CPB, Godula M, Yusa V, Manes J, Sorina JM, Soler C. Evaluation of mycotoxins and their metabolites in human breast milk using liquid chromatography coupled to high resolution mass spectrometry. Analyt Chim Acta 2014;820:39-46. doi: 10.1016/j.aca.2014.02.00910.1016/j.aca.2014.02.00924745736Search in Google Scholar

98. Smoragiewicz W, Cossette B, Boutard A, Krzystyniak K. Trichothecene mycotoxins in the dust of ventilation systems in office buildings. Int Arch Occup Environ Health 1993;65:113-7. doi: 10.1007/BF0040572910.1007/BF004057298253508Search in Google Scholar

99. Dearborn DG, Yike I, Sorenson WG, Miller MJ, Etzel RA. Overview of investigations into pulmonary hemorrhage amogn infants in Cleveleand, Ohio. Environ Health Perspect 1999;107(Suppl 3):495-9. PMID: 1034699810.1289/ehp.99107s3495156621710346998Search in Google Scholar

100. Center for Disease Control. Update: Pulmonary hemorrhage/ hemosiderosis among infants - Cleveland, Ohio, 1993-1996. CDC MMWR 2000;49:180-4.Search in Google Scholar

101. Zinedine A, Soriano JM, Moltó JC, Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem Toxicol 2007;45:1-18. PMID: 1704538110.1016/j.fct.2006.07.03017045381Search in Google Scholar

102. Waskiewicz A, Gromadzka K, Bocianowski J, Pluta P, Golinski P. Zearalenone contamination of the aquatic environment as a result of its presence in crops. Arh Hig Rada Toksikol 2012;63:429-35. doi: 10.2478/10004-1254-63-2012-222910.2478/10004-1254-63-2012-222923334037Search in Google Scholar

103. Saenz de Rodriguez CA. Envirnomental hormone contamination in Puerto Rico. New Engl J Med 1984;310:1741-42. PMID: 623349010.1056/NEJM1984062831026126233490Search in Google Scholar

104. Szuets P, Meserhazy A, Falklay GY, Bartok T. Early thelarche symptoms in children and their relations to zearalenon contamination in foodstuffs. Cereal Res Commun 1997;25:429-36.10.1007/BF03543747Search in Google Scholar

105. EFSA. Scientific opinion on the risk for public health related to the presence of zearalenone in food. EFSA J 2011:9:1-91. doi: 102903/j.efsa.2011.219710.2903/j.efsa.2011.2197Search in Google Scholar

106. Sorriano JM, Dragacci S. Occurrence of fumonisins in foods. Food Res Int 2004;37:985-1000. doi: 10.1016/j. foodres.2004.06.009Search in Google Scholar

107. Stevens VL, Tang J. Fumonisin B1-induced sphingolipid d e p l e t i o n i n h i b i t s v i t a m i n u p t a k e v i a t h e glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem 1997;272:18020-5. doi: 10.1074/jbc.272.29.1802010.1074/jbc.272.29.180209218430Search in Google Scholar

108. Bhat RV, Shetty PH, Amruth RP, Sudershan RV. A foodborne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins. J Toxicol Clin Toxicol 1997;35:249-55. PMID: 914031810.3109/155636597090012089140318Search in Google Scholar

109. Marasas WFO, Jaskiewicz K, Venter FS, Van Schalkwyk DJ. Fusarium moniliforme contamination of maize in esophageal cancer aereas in Transkei. S Afr Med J 1988;74:110-4. PMID: 3399988Search in Google Scholar

110. International Programme on Chemical Safety (IPCS). Fumonisin B1. Environmental Health Criteria. Vol 219. Geneva: WHO; 2000.Search in Google Scholar

111. Hendricks KA, Simpson JS, Larsen RD. Neural tube defect along the Texas-Mexico border, 1993-1995. Am J Epidemiol 1999;149:119-27. PMID: 1036950610.1093/oxfordjournals.aje.a00976610369506Search in Google Scholar

112. Ncayiyana DJ. Neural tube defects among rural blacks in a Transkei district. A preliminary report and analysis. S Afr Med J 1986;69:618-20. PMID: 3704839Search in Google Scholar

113. Golalipour MJ, Mobasheri E, Vakili MA, Keshtkar AA. Epidemiology of neural tube defects in northern Iran, 1998-2003. East Mediterr Health J 2007;13:560-6. PMID: 17687828Search in Google Scholar

114. Lian ZH, Yang HY, Li Z. Neural tube defects in Beijing- Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. J Epidemiol Commun Health 1987;41:259-62. PMID: 344382010.1136/jech.41.3.25910526323443820Search in Google Scholar

115. Berry RJ, Li Z, Erickson D, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong L-YC, Gindler J, Hong S-X. Prevention of neural-tube defects with folic acid in China N Engl J Med 1999;341:1485-90. doi: 10.1056/ NEJM19991111341200110.1056/NEJM19991111341200110559448Search in Google Scholar

116. Digra NC. Primary prevention of neural tube defects. JK Science 2004;6:1-3.Search in Google Scholar

117. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005;116:580-6. doi: 10.1542/peds.2005-059210.1542/peds.2005-059216140696Search in Google Scholar

118. Hendricks K, Larsen R, Suarez L. Neural tube defect surveillance and folic acid intervention - Texas Mexico Border, 1993-1998. CDC MMWR 2000;49:1-4.Search in Google Scholar

119. Suarez L, Hendircks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans livnig on US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol 2000;152:1017-23. doi: 10.1093/aje/152.11.101710.1093/aje/152.11.101711117610Search in Google Scholar

120. Domijan A-M. Fumonisin B1: a neurotoxic mycotoxin. Arh Hig Rada Toksikol 2012;63:531-44. doi: 10.2478/10004-1254-63-2012-223910.2478/10004-1254-63-2012-223923334049Search in Google Scholar

121. Flieger M, Wurst M, Shelby R. Ergot alkaloids - sources, structures and analytical methods. Folia Microbiol (Praha) 1997; 42:3-30. PMID:916099910.1007/BF028986419160999Search in Google Scholar

122. World Health Organization (WHO). Selected mycotoxins: ochratoxins, trichothecens, ergot. Report of an Expert Committee. Environmental Health Criteria No. 105. Geneva: WHO; 1990.Search in Google Scholar

123. Peraica M, Rašić D. The impact of mycotoxicoses on human history. Arh Hig Rada Toksikol 2012;63:511-6. doi: 10.2478/10004-1254-63-2012-225910.2478/10004-1254-63-2012-225923334047Search in Google Scholar

124. EFSA. Scientific opinion on ergot alkaloids in food and feed. EFSA J 2012;10:1-158. doi: 10.2903/j.efsa.2012.279810.2903/j.efsa.2012.2798Search in Google Scholar

125. King B. Outbreak of ergotism in Wollo, Ethiopia. Lancet 1979;1(8131):1411. PMID: 87875Search in Google Scholar

126. Caporeal LR. Ergotism: The satan losed in Salem? Science 1976;192:21-6. doi: 10.1126/science.76915910.1126/science.769159769159Search in Google Scholar

127. Liu X, Luo X, Hu W. Arthrinium sp. and the deteriorated sugarcane poisoning. In: Aibara K, Kumagai S, Ohtsubo K, Yoshizawa T, editors. Mycotoxins and phycotoxins, Abstracts of the Seventh International IUPAC Symposium, Tokyo 1988. Tokyo: Japanese Association of Mycotoxicology; 1988. p. 26.Search in Google Scholar

128. Liu X, Luo X, Hu W. Studies on epidemiology and etiology of moldy sugarcane poisoning in China. Biomed Environ Sci 1992;5:161-77. PMID: 1642790Search in Google Scholar

129. Ming L. Moldy sugarcane poisoning - a case report with a brief review. J Toxicol Clin Toxicol 1995;33:363-7. PMID: 762990510.3109/155636595090289247629905Search in Google Scholar

130. Urbany M. Dva daljnja slučaja ustilaginizma [Two new cases of ustilagnism, in Croatian]. Liječ Vjesn 1942;64:165-9.Search in Google Scholar

131. Urbany M. Slučaj infantilne akrodinije s recidivom [Case of acrodinia with recidivism, in Croatian]. Liječ Vjesn 1943;65:159-62 Search in Google Scholar

eISSN:
0004-1254
Langues:
Anglais, Slovenian
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Sciences médicales de base, autres